Financials Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 11:36:11 2024-04-12 am EDT 5-day change 1st Jan Change
86.47 EUR -0.23% Intraday chart for Sanofi -1.00% -3.67%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 112,310 98,877 111,194 112,665 112,549 107,963 - -
Enterprise Value (EV) 1 128,816 107,666 121,177 119,102 120,342 114,914 110,825 105,668
P/E ratio 40 x 8.01 x 17.8 x 16.7 x 20.8 x 14.6 x 12.3 x 11.1 x
Yield 3.51% 4.07% 3.76% 3.96% 4.19% 4.41% 4.8% 5.04%
Capitalization / Revenue 3.11 x 2.74 x 2.94 x 2.62 x 2.61 x 2.34 x 2.17 x 2.07 x
EV / Revenue 3.57 x 2.99 x 3.21 x 2.77 x 2.79 x 2.49 x 2.23 x 2.03 x
EV / EBITDA 10.8 x 9.41 x 9.95 x 8.14 x 8.44 x 8.27 x 7.14 x 6.41 x
EV / FCF 21.7 x 15.4 x 15 x 14 x 14.2 x 17 x 12.2 x 10.4 x
FCF Yield 4.6% 6.48% 6.68% 7.12% 7.04% 5.87% 8.23% 9.65%
Price to Book 1.9 x 1.57 x 1.62 x 1.5 x 1.52 x 1.42 x 1.31 x 1.28 x
Nbr of stocks (in thousands) 1,253,178 1,256,375 1,255,293 1,254,060 1,253,891 1,248,558 - -
Reference price 2 89.62 78.70 88.58 89.84 89.76 86.47 86.47 86.47
Announcement Date 2/6/20 2/5/21 2/4/22 2/3/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 36,126 36,041 37,761 42,997 43,070 46,120 49,738 52,097
EBITDA 1 11,904 11,443 12,183 14,627 14,259 13,893 15,513 16,477
EBIT 1 9,758 9,762 10,714 13,040 12,670 12,317 13,809 14,824
Operating Margin 27.01% 27.09% 28.37% 30.33% 29.42% 26.71% 27.76% 28.45%
Earnings before Tax (EBT) 1 2,822 13,804 7,798 8,268 7,038 9,894 12,050 13,687
Net income 1 2,806 12,314 6,223 6,720 5,400 7,381 8,787 9,676
Net margin 7.77% 34.17% 16.48% 15.63% 12.54% 16% 17.67% 18.57%
EPS 2 2.240 9.820 4.970 5.370 4.310 5.926 7.041 7.759
Free Cash Flow 1 5,928 6,982 8,096 8,483 8,478 6,748 9,116 10,195
FCF margin 16.41% 19.37% 21.44% 19.73% 19.68% 14.63% 18.33% 19.57%
FCF Conversion (EBITDA) 49.8% 61.02% 66.45% 58% 59.46% 48.57% 58.76% 61.87%
FCF Conversion (Net income) 211.26% 56.7% 130.1% 126.24% 157% 91.43% 103.74% 105.36%
Dividend per Share 2 3.150 3.200 3.330 3.560 3.760 3.813 4.154 4.356
Announcement Date 2/6/20 2/5/21 2/4/22 2/3/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 10,432 9,994 9,674 10,116 12,482 10,725 10,222 9,965 11,964 10,919 10,265 10,510 12,766 11,843 10,975
EBITDA 1 3,952 2,623 3,426 3,163 4,931 3,107 3,703 3,087 4,460 3,009 3,018 2,912 4,271 2,599 -
EBIT 1 3,558 2,256 3,065 2,753 4,498 2,724 3,333 2,726 4,028 2,583 2,756 2,582 4,140 2,815 3,175
Operating Margin 34.11% 22.57% 31.68% 27.21% 36.04% 25.4% 32.61% 27.36% 33.67% 23.66% 26.85% 24.57% 32.43% 23.77% 28.93%
Earnings before Tax (EBT) 1 2,957 1,391 2,349 1,383 2,666 1,921 2,468 1,718 2,971 -249 1,829 1,827 3,635 2,303 -
Net income 1 2,317 1,131 2,009 1,175 2,076 1,460 1,995 1,435 2,525 -555 1,608 1,542 2,790 1,592 -
Net margin 22.21% 11.32% 20.77% 11.62% 16.63% 13.61% 19.52% 14.4% 21.1% -5.08% 15.67% 14.68% 21.85% 13.44% -
EPS 2 1.850 0.9000 1.610 0.9400 1.660 1.160 1.600 1.150 2.010 -0.4400 1.282 1.227 2.218 1.267 -
Dividend per Share 2 - 3.330 - - - 3.560 - - - 3.760 0.9292 0.9292 0.9292 0.9292 0.9884
Announcement Date 10/28/21 2/4/22 4/28/22 7/28/22 10/28/22 2/3/23 4/27/23 7/28/23 10/27/23 2/1/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 16,506 8,789 9,983 6,437 7,793 6,951 2,862 -
Net Cash position 1 - - - - - - - 2,295
Leverage (Debt/EBITDA) 1.387 x 0.7681 x 0.8194 x 0.4401 x 0.5465 x 0.5004 x 0.1845 x -
Free Cash Flow 1 5,928 6,982 8,096 8,483 8,478 6,748 9,116 10,195
ROE (net income / shareholders' equity) 12.7% 12.1% 12.5% 14.4% 13.6% 12.3% 13.7% 14.3%
ROA (Net income/ Total Assets) 2.5% 6.47% 5.3% 8.37% 4.27% 6.74% 7.27% 7.58%
Assets 1 112,072 190,442 117,327 80,248 126,517 109,493 120,861 127,613
Book Value Per Share 2 47.20 50.30 54.80 59.70 59.20 60.80 66.00 67.60
Cash Flow per Share 2 6.160 5.940 8.360 8.410 8.200 8.120 10.40 11.80
Capex 1 1,816 1,329 2,043 2,201 3,024 2,144 2,270 2,334
Capex / Sales 5.03% 3.69% 5.41% 5.12% 7.02% 4.65% 4.56% 4.48%
Announcement Date 2/6/20 2/5/21 2/4/22 2/3/23 2/1/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
86.47 EUR
Average target price
107.2 EUR
Spread / Average Target
+24.03%
Consensus